Cory Trio is an associate in the firm’s Washington, DC office where he is a member of the Food, Drug, and Device Practice Group. Cory helps food, dietary supplement, OTC drug, and consumer product clients navigate a broad range of U.S. regulatory requirements. He has wide-ranging expertise on FDA and USDA food safety and manufacturing requirements, including FDA’s Food Safety Modernization Act (FSMA) regulations. He regularly advises clients on the development and implementation of food safety and quality programs and in responding to regulatory inspections, product recalls, and quality events. Cory also counsels clients on product labeling and claim substantiation issues, helping clients advance their marketing goals while mitigating regulatory and litigation risks.

Cory counsels OTC drug manufacturers on product development, labeling, and manufacturing issues, with a particular focus on helping clients navigate the CARES Act OTC monograph reforms. He also advises clients across product categories on FDA’s import and export requirements.